Proof of Concept Study of the Effectiveness of Ozurdex in Lieu of Oral Corticosteroids for the Control of Active Intermediate and Posterior Uveitis Requiring Immunosuppressive Drug Therapy
Phase of Trial: Phase IV
Latest Information Update: 08 Jul 2019
Price : $35 *
At a glance
- Drugs Dexamethasone (Primary)
- Indications Intermediate uveitis; Posterior uveitis
- Focus Proof of concept; Therapeutic Use
- 26 Jun 2019 Status changed from recruiting to completed.
- 02 Oct 2018 Planned End Date changed from 1 Dec 2018 to 30 Jun 2019.
- 02 Oct 2018 Planned primary completion date changed from 1 Sep 2018 to 30 Jun 2019.